Skip to search formSkip to main contentSkip to account menu

Amplimexon

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Imexon

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
A phase I study of imexon inj plus gemcitabine as first-line therapy for advanced pancreatic cancer with preclinical mechanistic study of dose limiting toxicity
4619 Background: Imexon, inj. (Amplimexon, AMP) is a novel cyanoaziridine (MW: 111) which depletes thiols inducing oxidative… 
2006
2006
Phase I/II trial of Amplimexon (imexon, inj.) plus dacarbazine in patients with stage III or IV malignant melanoma
Description High molecular weight-melanoma associated antigen (HMW-MAA) is conjugating chondrotin sulfate proteoglycan 4 and… 
2006
2006
432 POSTER Phase I study of Amplimexon™ (imexon, inj.) in patients with advanced solid tumors and lymphomas: final report
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)